Our studies showed that in gastric cancer cells, celastrol was observed to decrease phosphorylation of IκB and subsequent inhibition of NF-κB signaling pathway, exhibiting an anti-tumor potential. This evidence concerns the gene NFKB1 and gastric cancer.